Hepatitis B: New approaches for antiviral chemotherapy

Antiviral Chemistry and Chemotherapy

Volumn 7, Issue 2, 1996, Pages 53-64

  Locarnini, S A ^a   Civitico, G M ^a   Newbold, J E ^b  

^a FAIRFIELD HOSPITAL   (Australia)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis B; Nucleoside analogues; Penciclovir; Reverse transcriptase; Supercoiled DNA; Topoisomerase inhibitors

Indexed keywords

AMSACRINE; ANTIVIRUS AGENT; CAMPTOTHECIN; COUMAMYCIN A1; DNA POLYMERASE; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ELLIPTICINE; ETOPOSIDE; GANCICLOVIR; LAMIVUDINE; MITOXANTRONE; NALIDIXIC ACID; NUCLEOSIDE DERIVATIVE; PENCICLOVIR; TENIPOSIDE; VIRUS DNA;

ANTIVIRAL ACTIVITY; CHRONIC HEPATITIS; DNA SUPERCOILING; DRUG DESIGN; DRUG SCREENING; DRUG TARGETING; GENETIC TRANSCRIPTION; HEPATITIS B; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; REVIEW; VIRUS REPLICATION;

EID: 0029878146     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029600700201     Document Type: Review

References (65)

1. Bartenschlager, R., and Schaller, H. (1988) The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J 7: 4185-4192.
2. Bavand, M., Feitelson, M., and Laub, O. (1989) The hepatitis B virus-associated reverse transcriptase is encoded by the viral pol gene. J Virol 63: 1019-1021.
3. Bock, C., Schranz, P., Schroder, C.H., and Zentegraf, H. (1994) Hepatitis B virus genome is organised into nucleosomes in the nucleus of the infected cell. Virus Genes 8: 215-229.
4. Bonven, B.J., Gocke, E., and Westergaard, O. (1985) A high affinity topoisomerase I binding sequence is clustered at DNase I hypersensitive sites in tetrahymena R-chromatin. Cell 41: 541-551.
5. Brunette, M.R., Stemler, M., Bonino, F., Schodel, F., Oliveri, F., Rizzetto, M., Verme, G., and Will, H. (1990) A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol 10: 258-261.
6. Caceres, J.F., Blangy, D., and Glikin, G.C. (1989) Requirement of DNA topoisomerases for in vitro chromatin assembly by 3T6 mouse cell extracts. Eur J Biochem 181: 531-537.
7. Capranico, G., Jaxel, C., Roberge, M., Kohn, K.W., and Pommier, Y. (1990) Nucleosome positioning as a critical determinant for the DNA cleavage sites of mammalian DNA topoisomerase II in reconstituted simian virus 40 chromatin. Nucl Acids Res 18: 4453-4559.
8. Champoux, J.J., and Bullock, P.A. (1988) A possible role for the eukaryotic type 1 topoisomerase in illegitimate recombination. In Genetic recombination. R. Kucherlapati and G. Smith (eds). Washington D.C.:American Society for Microbiology, pp. 655-666
9. Civitico, G., and Locamini, S. (1994) The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures. Virology 203: 81-89.
10. Civitico, G., Wang, Y., Luscombe, C., Bishop, N., Tachedjian, G., Gust, I., Locarnini, S. (1990) Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled DNA active compounds. J Med Virol 31: 90-97.
11. Culotta, V., and Sollner-Webb, B. (1988) Sites of topoisomerase I action on X. laevis ribosomal chromatin: transcriptionally active rDNA has an ≈200 bp repeating structure. Cell 52: 585-597.
12. Dammann, R., Lucchini, R., Koller, T. and Sogo, J.M. (1993) Chromatin structures and transcription of rDNA in yeast Saccharomyces cerevisiae. Nucleic Acids Res 10: 2331-2338.
13. D'Arpa, P., and Liu, L.F. (1989) Topoisomerase targeting antitumor drugs. Biochem Biophys Acta 989: 163-177.
14. Dean, J., Bowden, S., and Locarnini, S. (1995) Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir. Antiviral Res 27: 171-178.
15. Dienstag, J.L , Perrillo, R.P , Schiff, E.R., Bartholomew, M., Vicary, C., and Rubin, M. (1994) Double-blind, randomized, three-month, dose-ranging trial of lamivudine for chronic hepatitis B. Hepatology 20: 199 A.
16. Duguet, M., Lavenot, C., Harper, F., Mirambeau, G., and Derecondo, A.M. (1983) DNA topoisomerase from rat liver: physiological variations. Nucl Acids Res 11: 1059-1075.
17. Eckart, S.G., Milich, D.R., and McLachlan, A. (1991) Hepatitis B virus core antigen has two nuclear localization sequences in the arginine rich carboxyl terminus. J Virol 65: 575-582.
18. Epstein, R.J. (1988) Topoisomerases in human disease. Lancet 1: 521-524.
19. Fourel, I., Cullen, J.M., Saputelli, J., Aldrich, C.E., Schaffer, P., Averett, D.R., Pugh, J., and Mason, W.S. (1994) Evidence that hepatocyte turnover is required for rapid clearance of DHBV during antiviral therapy of chronically infected ducks. J Virol 68: 8321-8330.
20. Fourel, I., Li, J., Hantz, O., Jacquet, C., Fox, J.J., and Trepo, C. (1992) Effects of 2′-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks. J Med Virol 37: 122-126.
21. Fowler, M.J.F., Monjardino, J., Tsiquaye, K.N., Zuckerman, A.J., and Thomas, H.C. (1984) The mechanism of replication of hepatitis B virus: evidence of asymmetric replication of the two DNA strands. J Med Virol 13: 83-91.
22. Griffith, J.D. (1975) Chromatin structure: deduced from a minichromosome. Science 187: 1202-1203.
23. Hirota, K., Sherker, A.H., Omata, M., Yokosuka, O., and Okuda, K. (1987) Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection. Hepatology 7: 24-28.
24. Hruska, J.F., Clayton, D.A., Rubenstein, J.L.R., and Robinson, W.S. (1977) Structure of hepatitis B Dane particle DNA before and after the Dane particle DNA polymerase reaction. J Virol 21: 666-672.
25. Junker-Niepmann, M., Bartenschlager, R., and Schaller, H. (1990) A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging for foreign RNA. EMBO J 9: 3389-3396.
26. Koch, J., and Schlict, H-J. (1993) Analysis of the earliest steps of hepadnaviral replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J Virol 67: 4874-4876.
27. Lanford, R.E., Notvall, L., and Beames, B. (1995) Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J Virol 69: 4431-4439.
28. Lenhoff, R.J., and Summers, J. (1994) Co-ordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J Virol 68: 4565-4571.
29. Liu, L.F., and Wang, J.C. (1987) Supercoiling of the DNA template during transcription. Proc Natl Acad Sci (USA) 84: 7024-7027.
30. Locarnini, S.A., and Cunningham, A. (1995) Clinical treatment of viral hepatitis. In: Antiviral Chemotherapy. E. de Clerq and D. Jeffries (eds). John Wiley & Sons Ltd, Chichester, pp. 441-530.
31. Lok, A. (1994) Treatment of chronic hepatitis B. Journal of Viral Hepatitis 1: 105-124.
32. Luscombe, C., Pedersen, J., Bowden, S., and Locarnini, S. (1994) Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy. Liver 14: 182-192.
33. Luscombe, C., Wang, Y., Pedersen, J., and Locarnini, S. (1995) Long term antiviral combination chemotherapy for duck hepatitis B virus infection using ganciclovir and nalidixic acid in vivo. Antiviral Res 26: A123.
34. Mason, W.S., Cullen, J., Saputelli, J., Wu, T-T., Liu, C., London, W.T., Lustbader, E., Schaffer, P., O'Connell, A.P., Fourel, I., Aldrich, C.E., and Jilbert, A.R. (1994) Characterization of the antiviral effects of 2′ carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology 19: 398-411.
35. Mason, W.S., Taylor, J.M., and Hull, R. (1987) Retroid virus genome replication, Adv Virus Res 32: 35-96.
36. Newbold, J., Xin, H., Tencza, M., Sherman, G., Dean, J., Bowden, S., and Locamini, S. (1995) The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 60: 3350-3357.
37. Oberhaus, S., and Newbold, J. (1993) Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay. J Virol 67: 6558-6566.
38. Oberhaus, S., and Newbold, J. (1995) Detection of an RNase H activity associated with hepadnaviruses. J Virol 69: 5697-5704.
39. Omata, M., Katsutaro, H., and Yokosuka, O. (1986) In vivo study of the mechanism of action of antiviral agents against hepadnavirus replication in the liver. J Hepatology 3: S49-S55.
40. Osheroff, N. (1989) Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmac Ther 41: 223-241.
41. Ramsperger, U., and Stahl, H. (1995) Unwinding of chromatin by the SV40 large T antigen DNA helicase. EMBO J 14: 3215-3225.
42. Shaw, T., Amor, P., Civitico, G., Boyd, M., and Locarnini, S. (1994) In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother 38: 719-723.
43. Shen, L.L., and Rernet, A.G. (1985) Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA. Proc Natl Acad Sci USA 82: 307-311.
44. Sherker, A.H., Hirota, K., Omata, M., and Okuda, K. (1986) Foscamet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks. Gastroenterology 91: 818-624.
45. Sherker, A , and Marion, P. (1991) Hepadnaviruses and hepatocellular carcinoma. Annu Rev Microbiol 45: 475-508.
46. Shin, J.H., and Rho, H.M. (1995) Release of the hepatitis B virus-associated DNA polymerase from the viral particle by the proteolytic cleavage. J Biol Chem 270: 11047-11050.
47. Summers, J., and Mason, W. (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29: 403-415.
48. Summers, J., Smith, P.M., and Horwich, A.L (1990) Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 54: 2819-2824.
49. Summers, J., Smith, P.M., Huang, M., and Yu, M. (1991) Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J Virol 65: 1310-1317.
50. Tavis, J. E., Perri, S., and Ganem, D. (1994) Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J Virol 68: 3536-3543.
51. Tuttleman, J.S., Pourcel, C., and Summers, J.W. (1986) Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47: 451-460.
52. Vosberg, H.P. (1985) DNA topoisomerases: Enzymes that control DNA conformation. Curr Top Microbiol Immunol 114: 19-102.
53. Wang, J.C. (1985) DNA topoisomerases. Ann Rev Biochem 54: 665-697.
54. Wang, Y., Bowden, S., Shaw, T., Civitico, G., Qiao, M., and Locarnini, S. (1991) Inhibition of duck hepatitis B virus replication in vivo by the nucleoside analogue ganciclovir (9-[2-hydroxy-1- (hydroxymethyl)ethoxymethyl]guanine). Antiviral Chem Chemother 2: 107-114.
55. Wang, Y., Luscombe, C., Bowden, S., Shaw, T., and Locamini, S. (1995) Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid. Antimicrob Agents Chemother 39: 556-558.
56. Wang, G.H., and Seeger, C. (1992) The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71: 663-670.
57. Wang, G.H., and Seeger, C. (1993) Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 67: 6507-6512.
58. Weber, M., Bronsema, V., Bartos, H., Bosserhoff, A., Bartenschlager, R., and Schaller, H. (1994) Hepadnavirus protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J Virol 68: 2994-2999.
59. Will, H., Reiser, W., Weimer, T., Pfaff, E., Buscher, M., Sprengel, R., Cattaneo, R., and Schaller, H. (1987) Replication strategy of human hepatitis B virus. J Virol 61: 904-911.
60. Wolffe, A.P. (1994) Transcription in tune with the histones. Cell 77: 13-16.
61. Wu, T-T., Coates, L., Aldrich, C.E., Summers, J., and Mason, W.S. (1990) In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular conversion pathway. Virology 175: 255-261.
62. Yang, L., Rowe, T.C., Nelson, E.M., and Liu, L.F. (1985) In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV 40 chromatin. Cell 41: 127-132.
63. Yokosuka, O., Omata, A., Imazeki, F., Okuda, K., and Summers, J. (1985) Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA. Hepatology 5: 728-734.
64. Zoulim, F., and Seeger, C. (1994) Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol 68: 6-13.
65. Zucker, K., and Worcel, A. (1990) The histone H3 H1 complex supplemented with histone H2A-H2B dimers and DNA topoisomerase I forms nucleosomes on circular DNA under physiological conditions. J Biol Chem 265: 14487-14496.